The United States is currently facing an unprecedented shortage of cancer drugs. While experts do not see an end in sight, more attention is being given to the issue by media and lawmakers, prompting think tanks, members of congress, and the Biden administration to determine solutions.

©2023 American Association for Cancer Research
2023
American Association for Cancer Research
You do not currently have access to this content.